ARIUS responds to recent market activity
Friday May 16, 3:00 pm ET
TORONTO, May 16 /CNW/ - ARIUS Research Inc., (TSX: ARI - News), a biotechnology company discovering and developing the next wave of antibody therapeutics, today responded to an inquiry by Market Regulation Services of the Toronto Stock Exchange, regarding market activity of the Company's shares.
As previously presented at its annual general meeting of shareholders, as part of its ongoing strategic development and in the normal course of its business, ARIUS continues to evaluate its strategic options with global pharmaceutical and biotechnology companies. Through this process, some third parties have shown interest in the Company and its technologies. At this stage, the Company has not entered into any agreement with any such third party. There are no assurances that this activity will result in any specific transaction and no specific timetable for the completion of any transaction is currently known. In addition, ARIUS has been presenting at various scientific and investor meetings, and will be presenting several abstracts at ASCO 2008. |
